Prospective Granting of an Exclusive License, 57687-57688 [E9-26939]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 215 / Monday, November 9, 2009 / Notices
Persons planning to attend should register
online at: https://oba.od.nih.gov/biosecurity/
biosecurity_meetings.html or by calling the
Dixon Group (Contact: Marianne Tshihamba
at (202) 281–2800). Individuals who plan to
attend and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should indicate
these requirements upon registration.
This meeting will also be Webcast. To
access the Webcast, as well as the draft
meeting agenda and pre-registration
information, connect to: https://
oba.od.nih.gov/biosecurity/
biosecurity_meetings.html. Please check this
site for updates.
Any member of the public interested in
presenting oral comments at the meeting may
notify the Contact Person listed on this notice
at least 10 days in advance of the meeting.
Interested individuals and representatives of
an organization may submit a letter of intent,
a brief description of the organization
represented, and a short description of the
oral presentation. Only one representative of
an organization may be allowed to present
oral comments. Both printed and electronic
copies are requested for the record. In
addition, any interested person may file
written comments with the committee. All
written comments must be received by
November 24, 2009 and should be sent via
e-mail to nsabb@od.nih.gov with ‘‘NSABB
Public Comment’’ as the subject line or by
regular mail to 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892, Attention Ronna
Hill. The statement should include the name,
address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
Dated: November 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–26933 Filed 11–6–09; 8:45 am]
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Nature’s
Solutions.
Date: December 1, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Anshumali Chaudhari,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892. (301) 435–
1210. chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Developmental Pharmacology.
Date: December 15–16, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Janet M. Larkin, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1102,
MSC 7840, Bethesda, MD 20892. 310–435–
1026. larkinja@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 2, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–26925 Filed 11–6–09; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
mstockstill on DSKH9S0YB1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individualsassociated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Nov<24>2008
16:52 Nov 06, 2009
Jkt 220001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
57687
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Acute Kidney Injury
Ancillary Studies.
Date: December 4, 2009.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7791,
goterrobinsonc@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: November 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–26931 Filed 11–6–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Prospective Granting of an Exclusive
License
AGENCY: Technology Transfer Office,
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services.
ACTION: Notice.
SUMMARY: This is a notice in accordance
with 35 U.S.C. 209(e) and 37 CFR
404.7(a)(1)(i) that the Technology
Transfer Office, Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (DHHS), is contemplating the
granting of an exclusive worldwide
license to practice the invention
embodied in the patent application
referred to below to International
Rollforms, Inc., having a place of
business in Deptford, New Jersey. CDC
intends to grant rights to practice this
invention to no other licensees. The
patent rights in this invention have been
assigned to the government of the
United States of America. The patent to
be licensed is:
Title: Instrumented Rock Bolt, Data
Logger and User Interface System, CDC
Ref. #: I–017–01.
Patent No.: 7,324,007.
E:\FR\FM\09NON1.SGM
09NON1
57688
Federal Register / Vol. 74, No. 215 / Monday, November 9, 2009 / Notices
Filing Date: 12/27/2002.
Issue Date: 01/29/2008.
The prospective exclusive license will
be royalty-bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7.
This invention includes the use of
rock bolts, strain gauges and data
loggers to increase the stability of rock
mass comprising the roof and walls of
mines. Strain gauges affixed to the rock
bolts provide a measure of the strains
and hence the stresses which a rock bolt
is subjected to. The rock bolt may
include a data logger which is coupled
to receive signals from one or more
strain gauges, and to record these
signals to memory.
ADDRESSES: Requests for a copy of this
patent, inquiries, comments, and other
materials relating to the contemplated
license should be directed to Andrew
Watkins, Director, Technology Transfer
Office, Centers for Disease Control and
Prevention (CDC), 4770 Buford
Highway, Mailstop K–79, Atlanta, GA
30341, telephone: (770) 488–8610;
facsimile: (770) 488–8615. Applications
for an exclusive license filed in
response to this notice will be treated as
objections to the grant of the
contemplated exclusive license. Only
written comments and/or applications
for a license which are received by CDC
within thirty days of this notice will be
considered. Comments and objections
submitted in response to this notice will
not be made available for public
inspection, and, to the extent permitted
by law, will not be released under the
Freedom of Information Act, 5 U.S.C.
552.
Dated: October 30, 2009.
Tanja Popovic,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–26939 Filed 11–6–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
mstockstill on DSKH9S0YB1PROD with NOTICES
[Docket No. DHS–2009–0126]
Privacy Act of 1974; Department of
Homeland Security U.S. Immigration
and Customs Enforcement—013 Alien
Medical Records System of Records
Privacy Office, DHS.
Notice of Privacy Act system of
AGENCY:
ACTION:
records.
SUMMARY: In accordance with the
Privacy Act of 1974 the Department of
Homeland Security proposes to
VerDate Nov<24>2008
16:52 Nov 06, 2009
Jkt 220001
establish a new Department of
Homeland Security U.S. Immigration
and Customs Enforcement system of
records notice titled, Department of
Homeland Security U.S. Immigration
and Customs Enforcement—013 Alien
Medical Records System of Records.
This system maintains records that
document the medical screening,
examination, and treatment of aliens
arrested and detained by U.S.
Immigration and Customs Enforcement
for violations of the Immigration and
Nationality Act. The records contain the
medical information for aliens detained
in facilities owned and operated by U.S.
Immigration and Customs Enforcement
or its contractors, or in facilities where
medical care is provided by Department
of Health and Human Services Public
Health Service Commissioned Corps
Officers. The system also supports the
collection and maintenance of medical
information about these individuals and
its dissemination in the case of
infectious diseases, especially in the
event of a public health emergency,
such as an epidemic or pandemic. The
information described in this notice was
previously covered by a Department of
Health and Human Services Patients
Medical Record system of records. This
newly established system will be
included in the Department of
Homeland Security’s inventory of
record systems.
DATES: Submit comments on or before
December 9, 2009. This new system will
be effective December 9, 2009.
ADDRESSES: You may submit comments,
identified by docket number DHS–
2009–0126 by one of the following
methods:
• Federal e-Rulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Fax: 703–483–2999.
• Mail: Mary Ellen Callahan, Chief
Privacy Officer, Privacy Office,
Department of Homeland Security,
Washington, DC 20528.
• Instructions: All submissions
received must include the agency name
and docket number for this rulemaking.
All comments received will be posted
without change to https://
www.regulations.gov, including any
personal information provided.
• Docket: For access to the docket to
read background documents or
comments received go to https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: For
general questions please contact: Lyn
Rahilly (202–732–3300), Privacy Officer,
U.S. Immigration and Customs
Enforcement. For privacy issues please
contact: Mary Ellen Callahan (703–235–
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
0780), Chief Privacy Officer, Privacy
Office, U.S. Department of Homeland
Security, Washington, DC 20528.
SUPPLEMENTARY INFORMATION:
I. Background
The Alien Medical Records system of
records is maintained by the
Department of Homeland Security
(DHS) U.S. Immigration and Customs
Enforcement (ICE) Division of
Immigration Health Services (DIHS), a
division within the Office of Detention
and Removal Operations (DRO). As
noted above, the information described
in this notice was previously covered by
the Department of Health and Human
Services (HHS) 9–15–0002 Patients
Medical Record System Public Health
Service Hospitals HHS/HRSA/BPHC
System of Records (August 3, 2009, 74
FR 38456). This system of records
maintains medical, mental health, and
dental records that document the
medical screening, examination, and
treatment of aliens whom ICE arrests
and detains for violations of the
Immigration and Nationality Act (INA).
The records contain the medical
information for aliens detained in
facilities owned and operated by ICE or
its contractors, or in other facilities for
ICE detainees where medical care is
provided by ICE DIHS. It also maintains
information about prisoners of the U.S.
Marshals Service (USMS) who are
housed in a detention facility operated
by or on behalf of ICE pursuant to an
agreement between the USMS and ICE.
The system of records also supports the
dissemination of medical information
about these individuals in the case of
infectious diseases especially in the
event of a public health emergency,
such as an epidemic or pandemic.
Before October 1, 2007, DHS and HHS
maintained annual interagency
agreements through which ICE DIHS, a
component of HHS’s Health Resources
and Services Administration (HRSA),
provided health care for ICE detainees.
Medical records created by HRSA in
providing those services were covered
under a HHS Privacy Act system of
records notice titled HHS 9–15–0002
Patients Medical Record System Public
Health Service Hospitals HHS/HRSA/
BPHC System of Records (August 3,
2009, 74 FR 38456). On August 23,
2007, a new agreement between DHS
and HHS was signed to facilitate the
transfer of the Federal detainee health
care program responsibilities from HHS
to DHS and detailed Public Health
Service Commissioned Corps Officers to
DHS on an open-ended basis to provide
medical care for ICE detainees. HRSA
has disbanded its DIHS, and ICE has
E:\FR\FM\09NON1.SGM
09NON1
]]>Agencies
[Federal Register Volume 74, Number 215 (Monday, November 9, 2009)]
[Notices]
[Pages 57687-57688]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26939]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Prospective Granting of an Exclusive License
AGENCY: Technology Transfer Office, Centers for Disease Control and
Prevention (CDC), Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37
CFR 404.7(a)(1)(i) that the Technology Transfer Office, Centers for
Disease Control and Prevention (CDC), Department of Health and Human
Services (DHHS), is contemplating the granting of an exclusive
worldwide license to practice the invention embodied in the patent
application referred to below to International Rollforms, Inc., having
a place of business in Deptford, New Jersey. CDC intends to grant
rights to practice this invention to no other licensees. The patent
rights in this invention have been assigned to the government of the
United States of America. The patent to be licensed is:
Title: Instrumented Rock Bolt, Data Logger and User Interface
System, CDC Ref. : I-017-01.
Patent No.: 7,324,007.
[[Page 57688]]
Filing Date: 12/27/2002.
Issue Date: 01/29/2008.
The prospective exclusive license will be royalty-bearing and will
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
This invention includes the use of rock bolts, strain gauges and
data loggers to increase the stability of rock mass comprising the roof
and walls of mines. Strain gauges affixed to the rock bolts provide a
measure of the strains and hence the stresses which a rock bolt is
subjected to. The rock bolt may include a data logger which is coupled
to receive signals from one or more strain gauges, and to record these
signals to memory.
ADDRESSES: Requests for a copy of this patent, inquiries, comments, and
other materials relating to the contemplated license should be directed
to Andrew Watkins, Director, Technology Transfer Office, Centers for
Disease Control and Prevention (CDC), 4770 Buford Highway, Mailstop K-
79, Atlanta, GA 30341, telephone: (770) 488-8610; facsimile: (770) 488-
8615. Applications for an exclusive license filed in response to this
notice will be treated as objections to the grant of the contemplated
exclusive license. Only written comments and/or applications for a
license which are received by CDC within thirty days of this notice
will be considered. Comments and objections submitted in response to
this notice will not be made available for public inspection, and, to
the extent permitted by law, will not be released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: October 30, 2009.
Tanja Popovic,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E9-26939 Filed 11-6-09; 8:45 am]
BILLING CODE 4163-18-P
